Cyclin-dependent kinase-inhibitor 1 (CDKN1A) in the squamous epithelium of the oropharynx: Possible implications of molecular biology and compartmentation

Anticancer Research

Volumn 21, Issue 1 A, 2001, Pages 333-345

  Wagner, M ^a   Klussmann, J P ^a   Fangmann, R ^a   Linder, R ^a   Elewa, M E ^a   Eidt, S ^a   Rose, V M A ^a   Jungehulsing, M ^a   Schulze, H J ^a  

^a UNIVERSITY OF ESSEN MEDICAL SCHOOL   (Germany)

Author keywords

Cap20; CDKN1; CDKN1A; CDKNA1; Cip 1; Mda 6; P21; Pic1; Sdi 1; Waf 1

Indexed keywords

CASPASE; CYCLIN DEPENDENT KINASE INHIBITOR; GENE PRODUCT; PROTEIN P53;

APOPTOSIS; CARCINOGENESIS; CELL COMPARTMENTALIZATION; CELL DIFFERENTIATION; CELLULAR DISTRIBUTION; GENE REARRANGEMENT; GENETIC POLYMORPHISM; GENOME IMPRINTING; HETEROZYGOSITY LOSS; HUMAN; IMMUNOCYTOCHEMISTRY; KERATINOCYTE; MOLECULAR BIOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; OROPHARYNX CANCER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DEGRADATION; PROTEIN TRANSPORT; REVIEW; SOMATIC MUTATION; SQUAMOUS CELL CARCINOMA; WART VIRUS;

APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL COMPARTMENTATION; CELL DIFFERENTIATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; GENOMIC IMPRINTING; HUMANS; KERATINOCYTES; MUTATION; OROPHARYNGEAL NEOPLASMS; OROPHARYNX; POLYMORPHISM, GENETIC; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0035062424     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (195)

1. Induction of p53-, MDM2-, and WAF1/CIP1-like molecules in insect cells by DNA-damaging agents
2. Lack of mutation in the WAF1/CIP1 gene during bovine leukemia virus-induced leukemogenesis. Vet leukemogenesis
3. Molecular cloning, sequencing, chromosomal localization and expression of mouse p21 (Waf1)
4. Cloning and chromosome mapping of the feline genes p21WAF1 and p27Kip1
5. Cloning of feline p21WAF1 and p27Kip1 cDNAs and search for their aberration in leukemias and lymphomas in cats
6. UVB radiation induces p21cip1/waf1 and mediates G1 and S phase checkpoints
7. PCNA binding proteins in Drosophila melanogaster: The analysis of a conserved PCNA binding domain
8. Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit
9. Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21
10. p21 is a universal inhibitor of cyclin kinases
11. p53, the cellular gatekeeper for growth and division
12. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases
13. Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair
14. Cip1 inhibits DNA replication but not PCNA-dependent nucleotide excision-repair
15. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA
16. The C-terminal domain of p21 inhibits nucleotide excision repair In vitro and In vivo
17. The tumor suppression function of p21Waf is contained in its N-terminal half ('half-WAF')
18. The C-terminal region of p21SDI1/WAF1/CIP1 is involved in proliferating cell nuclear antigen binding but does not appear to be required for growth inhibition
19. p21WAF1 immunohistochemical expression in breast carcinoma: Correlations with clinicopathological data, oestrogen receptor status, MIB1 expression, p53 gene and protein alterations and relapse- free survival
20. Prognostic value of p21(WAF1) and p53 expression in breast carcinoma: An immunohistochemical study in 261 patients with long-term follow-up
21. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis
22. Decreased expression and rare somatic mutation of the CIP1/WAF1 gene in human hepatocellular carcinoma
23. Induction of WAF1/CIP1 by a p53-independent pathway
24. Loss of p21WAF1/CIP-1 expression correlates with disease progression in gastric carcinoma
25. p21 expression and mutation in gastric carcinoma: Analysis by immunohistochemistry and PCRSSCP
26. Overexpression of p21WAF1/CIP1 induces growth arrest, giant cell formation and apoptosis in human breast carcinoma cell lines
27. Expression of p21 (Waf1/Cip1) in head and neck cancer in relation to proliferation, differentiation; p53 status and cyclin D1 expression
28. Correlation and prognostic significance of p53, p21WAF1/CIP1 and Ki-67 expression in patients with superficial bladder tumors treated with bacillus Calmette-Guerin intravesical therapy
29. Effects of p21(Cip1/Waf1) at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication
30. Wavelength-specific induction of immediate early genes by ultraviolet radiation
31. Differential regulation of the AP-1 family members by UV irradiation in vitro and in vivo
32. UV-B/A irradiation of mouse keratinocytes results in p53-mediated waf/CIP1 expression
33. Involvement of the cell-cycle inhibitor Cip1/waf1 and the E1A-associated p300 protein in terminal differentiation
34. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen
35. Epigenetic modification and imprinting of the mammalian genome during development
36. Human DNA-(cytosine-5) methyltransferase-PCNA complex as a target for p21WAF1
37. Down-regulation of human DNA-(Cytosine-5) methyltransferase induces cell cycle regulators p16(ink4A) and p21(Waf/Cip1) by distinct mechanisms
38. Regulation of cyclin-dependent kinase inhibitor p21(WAF1/Cip1/Sdi1) gene expression in hepatic regeneration
39. The clinical significance of p21(WAF1/CIP-1) and p53 expression in pancreatic adenocarcinoma
40. WAF1/CIP1 protein expression in human breast tumors
41. High-risk HPV-positive human cancer cell lines show different sensitivity to cisplatin-induced apoptosis correlated with the p21Waf1/Cip1 level
42. Expression of p21 (waf1/cip1/sdi1), but not p53 protein, is a factor in the survival of patients with advanced gastric carcinoma
43. Association of loss of heterozygosity at the p53 locus with chemoresistance in osteosarcomas
44. Biomarkers for predicting response to regional chemo-immunotherapy in liver metastases from colorectal carcinoma
45. Expression and alteration of p53 and p21 (waf1/cip1) influence the sensitivity of chemoradiation therapy for esophageal cancer
46. Expression of p53 and p21 proteins in oral squamous cell carcinoma: Correlation with lymph node metastasis and response to chemoradiotherapy
47. P21/waf1/cip1 and mdm-2 expression in breast carcinoma patients as related to prognosis
48. P21(Waf1/Cip1) and p53 protein expression in breast cancer
49. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
50. p21(Waf1/Cip1) protects against p53- mediated apoptosis of human melanoma cells
51. Radiation-induced cell cycle arrest compromised by p21 deficiency
52. Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts
53. Antisense blockade of p21/waf1 decreases radiation- induced G2 arrest in esophageal squamous cell carcinoma
54. Herpes viral cyclin/Cdk6 complexes evade inhibition by CDK inhibitor proteins
55. Differential regulation of the p21/WAF-1 and mdm2 genes after high-dose UV irradiation: p53- dependent and p53-independent regulation of the mdm2 gene
56. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53
57. Up-regulation of p21WAF1 by phorbol ester and calcium in human keratinocytes through a protein kinase C-dependent pathway
58. Tumor necrosis factor alpha: Posttranscriptional stabilization of WAF1 mRNA in p53-deficient human leukemic cells
59. CCMT/enhancer-binding protein alpha (C/EBP alpha) inhibits cell proliferation through the p21 (WAF-1/CIP-1/SDI-1) protein
60. Irradiation induces WAF1 expression through a p53-independent pathway in KG-1 cells
61. Induction of cyclin-dependent kinase inhibitor p21 in vesnarinone- induced differentiation of squamous cell carcinoma cells
62. Prolonged induction of p21Cip1/WAF1/CDK2/PCNA complex by epidermal growth factor receptor activation mediates ligand-induced M31 cell growth inhibition
63. Growth inhibitory concentrations of EGF induce p21 (waf1/cip1) and alter cell cycle control in squamous carcinoma cells
64. In vitro growth suppression by adenoviral transduction of p21 and p16 in squamous cell carcinoma of the head and neck: A research model for combination gene therapy
65. Cloning and Characterization of a Novel p21(Cip1/Waf1)Interacting Zinc Finger Protein, Cizl
66. The relationship between p21/waf1 expression patterns and cell proliferation during the tumorigenesis of the bronchus
67. p21WAF-1 reorganizes the nucleus in tumor suppression
68. p21(cip-1/waf-1) deficiency causes defommed nuclear architecture, centriole overduplication, polyploidy, and relaxed microtubule damage checkpoints in human hematopoietic cells
69. Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival
70. Inhibition of oncogeme-mediated transformation by ectopic expression of p21Waf1 in NIH3T3 cells
71. Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorageindependent cells
72. Apoptosis and expression of p53 response proteins and cyclin D1 after cortical impact in rat brain
73. Increased level of p21 in human ovarian tumors is associated with increased expression of cdk2, cyclin A and PCNA
74. Decorin suppresses tumor cell growth by activating the epidermal growth factor receptor
75. Apoptosis inhibitory activity of cytoplasmic p21(Cip1/WAF1) in monocytic differentiation
76. Expression of a novel form of p21Cip1/Waf1 in UV-irradiated and transformed cells
77. Cleavage of CDK inhibitor p21(Cip1/Waf1) by caspases is an early event during DNA damage-induced apoptosis
78. Cleavage of p21Cip1/Waf1 and p27Kip1 mediates apoptosis in endothelial cells through activation of Cdk2: Role of a caspase cascade
79. Chromosomal mapping of the genes for the human cell cycle proteins cyclin C (CCNC), cyclin E (CCNE), p21 (CDKN 1) and KAP (CDKN 3)
80. Lack of imprinting of three human cyclin-dependent kinase inhibitor genes
81. WAF1/Cip1 gene polymorphism and expression in carcinomas of the breast, ovary, and endometrium
82. Infrequent mutation of Waf1/p21 gene, a CDK inhibitor gene, in brain tumors
83. Multiple polymorphisms, but no mutations, in the WAF1/CIP1 gene in human brain tumours
84. A single nucleotide substitution at codon 31 (Ser/Arg) defines a polymorphism in a highly conserved region of the p53-inducible gene WAF1/CIP1
85. The codon 31 polymorphism of the p53- inducible gene p21 shows distinct differences between major ethnic groups
86. No point mutation but a codon 31ser∼arg polymorphism of the WAF-1/CIP-1/p21 tumor suppressor gene in nasopharyngeal carcinoma (NPC): The polymorphism distinguishes Caucasians from Chinese
87. Mutational analysis of the p21/WAF1/CIP1/SDI1 coding region in human tumor cell lines
88. WAF1 genotype and endometrial cancer susceptibility
89. Association between the p21 codon 31 A1 (arg) allele and lung cancer
90. Mutations and polymorphisms in the p53, p21 and p16 genes in oral carcinomas of Indian betel quid chewers
91. Association between human cancer and two polymorphisms occurring together in the p21Waf1/Cip1 cyclin-dependent kinase inhibitor gene
92. Polymorphisms and probable lack of mutation in the WAF1-CIP1 gene in colorectal cancer
93. Analysis of the p21 gene in gliomas
94. Molecular pathology of primary and metastatic ductal pancreatic lesions: Analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions
95. Absence of WAF1 mutations in a variety of human malignancies
96. WAF1/CIP1 structural abnormalities do not contribute to cell cycle deregulation in ovarian cancer
97. Nachweis genetischer Alterationen in sporadischen Brusttumoren
98. Abrogation of apoptosis induced by DNA- damaging agents in human bladder-cancer cell lines with p21/WAF1/CIP1 and/or p53 gene alterations
99. A somatic mutation of the p21(Waf1/Cip1) gene in a human adrenocortical adenoma
100. Molecular analysis of the Cip1/Waf1 (p21) gene in diverse types of human tumors
101. Functional analysis of a p21WAF1,CIP1,SDI1 mutant (Arg94∼Trp) identified in a human breast carcinoma. Evidence that the mutation impairs the ability of p21 to inhibit cyclin-dependent kinases
102. Somatic mutations of the WAF1/CIP1 gene in primary prostate cancer
103. A mutant p21 cyclin-dependent kinase inhibitor isolated from a Burkitt's lymphoma
104. Evidence of gene deletion of p21 (WAF1/CIP1), a cyclin-dependent protein kinase inhibitor, in thyroid carcinomas
105. Mutations and defective expression of the WAF1 p21 tumoursuppressor gene in malignant melanomas
106. Absence of somatic changes in p21 gene in nonHodgkin's lymphoma and chronic myelogenous leukemia
107. Analysis of p21WAF1/CIP1 in primary bladder tumors
108. Identification and mapping of novel tumor suppressor loci on 6p in diffuse large B-cell non-Hodgkin's lymphoma
109. Expression and sequence analysis of the p21(WAF1/CIP1) gene in renal cancers
110. Absence of a mutation of the p21/waf1 gene in human lung and pancreatic cancers
111. Two variants of the CIP1/WAF1 gene occur together and are associated with human cancer
112. Polymorphisms in P21CIP1/WAF1 are not correlated with TP53 status in sporadic ovarian tumours
113. Enhanced expression of Ki-67, topoisomerase lla, PCNA, p53 and p21waf1/cip1 reflecting proliferation and repair activity in UV-irradiated melanocytic nevi
114. Oncogenic transformation of HPV-immortalized human oral keratinocytes is associated with the genetic instability of cells
115. p53-dependent induction of WAF1 by heat treatment in human glioblastoma cells
116. p53-dependent induction of WAF1 by cold shock in human glioblastoma cells
117. p53-dependent induction of WAF1 by a low-pH culture condition in human glioblastoma cells
118. WAF1, a potential mediator of p53 tumor suppression
119. Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F
120. Apoptotic response to oncogenic stimuli: Cooperative and antagonistic interactions between c-myb and the growth suppressor p53
121. Physical and functional interactions of neuronal growth suppressor necdin with p53
122. Loss of p21cip1/waf1 does not recapitulate accelerated malignant conversion caused by p53 loss in experimental skin carcinogenesis
123. Effects of 1,25 dihydroxyvitamin D3 and its analogues on induction of apoptosis in breast cancer cells
124. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage
125. p53- independent expression of p21Cip1 in muscle and otherterminally differentiating cells
126. p21 expression is increased by irradiation in esophageal squamous cell carcinoma
127. Induction of p21 (WAF-1/CIP1) during differentiation
128. Sodium butyrate induces NIH3T3 cells to senescence-like state and enhances promoter activity of p21WAF/CIP1 in p53-independent manner
129. Regulation of p21WAF1/CIP1 expression by p53-independent pathways
130. The role of the transcription factor Sp1 in regulating the expression of the WAF1/CIP1 gene in U937 leukemic cells
131. Functional analysis of the transforming growth factor beta responsive elements in the WAF1/Cip1/p21 promoter
132. Butyrate activates the WAF1/Cip1 gene promoter through Sp1 sites in a p53-negative human colon cancer cell line
133. Involvement of the Sp3 transcription factor in induction of p21cip1/waf1 in keratinocyte differentiation
134. Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiP1
135. p53-mediated transcriptional activity increases in differentiating epidermal keratinocytes in association with decreased p53 protein
136. Sp1, but not Sp3, functions to mediate promoter activation by TGF-beta through canonical Spl binding sites
137. Modifications of p53 protein and accumulation of p21 and gadd45 mRNA in TGFbeta 1 growth inhibited cells
138. Terminal differentiation of normal human oral keratinocytes is associated with enhanced cellular TGF-beta and phospholipase C-gamma 1 levels and apoptotic cell death
139. Immunohistochemical evaluation of TGF-beta and extracellular matrix proteins expression in rat squamous cell carcinomas
140. Up-regulation of p27Kip1, p21waf1/Cip1 and p161nk4a is associated with, but not sufficient for, induction of squamous differentiation
141. Multiple pathways control cell growth and transformation: Overlapping and independent activities of p53 and p21Cip1/WAF1/ Sdi1
142. Epidermal differentiation and squamous metaplasia from stem cell to cell death
143. p53 gene dosage modifies growth and malignant progression of keratinocytes expressing the v-rasHa oncogene
144. Effects of ethanol treatment of proliferation and differentiation in a head and neck squamous cell carcinoma cell line
145. Ethanol upregulates the expression of p21 waf1/CIP1 and prolongs G1 transition via a p53-independent pathway in human epithelial cells
146. A novel, nerve growth factor-activated pathway involving nitric oxide, p53, and p21WAF1 regulates neuronal differentiation of PC12 cells
147. Nitric oxide synthase type 3 is increased in squamous hyperplasia, dysplasia, and Squamous cell carcinoma of the head and neck
148. p21 (waf1/CIP1) expression is induced in newly nondividing cells in diverse epithelia and during differentiation of the Caco-2 intestinal cell line
149. Inhibitory function of p21cip1/waf1 in differentiation of primary mouse keratinocytes independent of cell cycle control
150. Differentiation and IFN gamma regulate waf1/cip1 transcription in p53- independent and p53-dependent pathways in epithelial cells
151. Down-regulation of p27Kip1 expression is correlated with increased cell proliferation but not expression of p21waf1 and p53, and human papillomavirus infection in benign and malignant tumours of sinonasal regions
152. Alterations in cyclin-dependent kinase 2 function during differentiation of primary human keratinocytes
153. The absence of p21Cip1/waf1 alters keradnocyte growth and differentiation and promotes ras-tumor progression
154. Possible involvement of p21 but not of p16 or p53 in keratinocyte senescence
155. p21 (waf1/Cip1) functions as a suppressor of malignant skin tumor formation and a determinant of keratinocyte stem-cell potential
156. p53- and p21-independent apoptosis of squamous cell carcinoma cells induced by 5-fluorouracil and radiation
157. Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA
158. Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1
159. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway
160. Identification of a p53-dependent negative response element in the bcl-2 gene
161. Interaction between bcl-2 and p21 (WAF1/CIP1) in breast carcinomas with wild-type p53
162. Aciivation of the cyclic AMP pathway by alpha- mediates the response of human melanocytes to ultraviolet B radiation
163. Post-transcriptional induction of p21cip1 protein by human papillomavirus E7 inhibits unscheduled DNA synthesis reactivated in differentiated keratinocytes
164. Concordant induction of cyclin E and p21cip1 in differentiated keratinocytes by the human papillomavirus E7 protein inhibits cellular and viral DNA synthesis
165. Overriling of cyclin-dependent kinase inhibitors by high and low risk human papillomavirus types: Evidence for an in vivo role in cervical lesions
166. Inhibition of CDK activity, and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein
167. The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2
168. HPV-16 oncogenes E6 and E7 are mutagenic in normal human oral keratinocytes
169. Initiation of DNA synthesis by human papillomavirus E7 oncoproteins is resistant to p21- mediated inhibition of cyclin E-cdk2 activity
170. Human papillomavirus 11 E5a delays the growth restriction induced by temperature shift in temperature-sensitive simian virus 40 T antigen-immortalized keratinocytes
171. Human papillomavirus type 11 and 16 E5 represses p21 (Waf1/Sdi1/Cip1) gene expression in fibroblasts and keratinocytes
172. Expression of cyclin dependent kinase inhibitor p21waf1/cip1 in premalignant and malignant oral lesions: Relationship with p53 status
173. Aberrant p21 (CIP1/waf1) protein accumulation in head-and-neck cancer
174. Concerted overexpression of the genes encoding p21 and cyclin D1 is associated with growth inhibition and differentiation in various carcinomas
175. Expression of p21/waf1 in oral squamous cell carcinomas - Correlation with p53 and mdm2 and cellular proliferation index
176. Increase in expression level of p21sdi1/cip1/waf1 with increasing division age in both normal and SV40-transformed human fibroblasts
177. Preneoplastic oral lesions: The clinical value of image cytometry DNA analysis, p53 and p21/waf1 expression
178. Expression of p53 and p21CIP1/waf1 proteins in oral epithelial dysplasias and squamous cell carcinomas
179. p53 mutations and p53, Waf-i, Bax and Bcl-2 expression in field cancerization of the head and neck
180. Relationship of p53 overexpression to other cell cycle regulatory, proteins in oral squamous cell carcinoma
181. Cell carcinomas
182. p21waf1/cip1/mda-6 expression in non-smallcell lung cancer: Relationship to survival
183. P21 expression as a predictor for favorable prognosis in squamous cell carcinoma of the lung
184. The clinicopathological significance of p21 and p53 expression in esophageal squamous cell carcinoma: An analysis of 153 patients
185. p21Waf1/Cip1 expression is a prognostic marker in curatively resected esophageal squamous cell carcinoma, but not p27Kip1, p53, or Rb
186. Expression of p21WAF1 predicts outcome of esophageal cancer patients treated by surgery, alone or by combined therapy modalities
187. Gene therapy for head and neck cancer. Comparing the tumor suppressor gene p53 and a cell cycle regulator waf1/CIP1 (p21)
188. p21 (waf1/Cip1) retards the growth of human squamous cell carcinomas in vivo
189. Advanced-stage cervical carcinomas are defined by a recurrent pattern of chromosomal aberrations revealing high genetic instability and a consistent gain of chromosome arm 3q
190. p53, through p21 (WAF1/CIP1), induces cyclin D1 synthesis
191. Positivity of the proliferation marker Ki-67 in noncycling cells
192. Cell cycle analysis of a cell proliferation associated human nuclear antigen defined by the monoclonal antibody Ki67
193. New Ki-67-equivalent murine monoclonal antibodies (MIB 1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope
194. Immunophenotypic analysis of normal mucosa and squamous cell carcinoma of the oral cavity
195. The influence of p53 and associated factors on the outcome of patients with oral squamous cell carcinoma